FDA schedules Aimmune's peanut allergy drug for September expert review

[cafead]

via Aimmune Therapeutics said Thursday the Food and Drug Administration's advisory committee on allergenic products will review its experimental peanut allergy pill in September, setting a date for an initial test of the growing allergy desensitization field.

article source